Fasting and post-oral-glucose-load levels of methylglyoxal are associated with microvascular, but not macrovascular, disease in individuals with and without (pre)diabetes: The Maastricht Study.

CONCLUSION: Fasting and post-OGTT MGO levels were associated with microvascular disease, but not prior CVD. Thus, therapeutic strategies directed at lowering MGO levels may prevent microvascular disease.
PMID: 32058030 [PubMed - as supplied by publisher]

Source: Diabetes and Metabolism - February 9, 2020 Category: Endocrinology Authors: Hanssen NM, Scheijen JLJM, Houben AJHM, van de Waarenburg M, Berendschot TTJM, Webers CAB, Reesink KD, Greevenbroek MMJV, Kallen CV, Schaper NC, Schram MT, Henry RMA, Stehouwer CDA, Schalkwijk CG Tags: Diabetes Metab Source Type: research